InVivo Therapeutics Holdings (FRA:04I) Other Operating Expense : €-0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is InVivo Therapeutics Holdings Other Operating Expense?

InVivo Therapeutics Holdings's Other Operating Expense for the three months ended in Sep. 2023 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.00 Mil.

InVivo Therapeutics Holdings's quarterly Other Operating Expense declined from Mar. 2023 (€-0.00 Mil) to Jun. 2023 (€-0.00 Mil) but then increased from Jun. 2023 (€-0.00 Mil) to Sep. 2023 (€-0.00 Mil).

InVivo Therapeutics Holdings's annual Other Operating Expense increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil) but then stayed the same from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

InVivo Therapeutics Holdings Other Operating Expense Historical Data

The historical data trend for InVivo Therapeutics Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InVivo Therapeutics Holdings Other Operating Expense Chart

InVivo Therapeutics Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

InVivo Therapeutics Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

InVivo Therapeutics Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

InVivo Therapeutics Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InVivo Therapeutics Holdings (FRA:04I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (FRA:04I) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

NVIV:USA

Address

One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139

Website

https://www.invivotherapeutics.com

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings (FRA:04I) Headlines

No Headlines